NCT02950012

A Study to Evaluate OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

A Randomized, Double-blind, Placebo-controlled, Parallel Study to Evaluate the Efficacy and Safety of OPTI-BIOME™ Bacillus Subtilis MB40 on Abdominal Discomfort, Gas and Bloating in a Healthy Population

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 100 (actual)
• Sponsor: BIO-CAT Microbials, LLC · Industry
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to investigate the effects of OPTI-BIOME™ (Bacillus subtilis MB40), a probiotic supplement, on bloating, gas and abdominal discomfort symptoms in otherwise healthy adults.

Conditions

• Bloating

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	OPTI-BIOME™ Bacillus subtilis MB40
OTHER	Placebo

Timeline

• Start date: 2016-10-01
• Primary completion: 2017-02-01
• Completion: 2017-02-01
• First posted: 2016-10-31
• Last updated: 2021-10-29

Locations

3 sites across 2 countries: United States, Canada